N

early a dozen members of Congress are urging the US Army not to issue an exclusive license to Sanofi Pasteur to develop a vaccine for the Zika virus over concerns the product may be priced too high for many Americans, even though it was developed with taxpayer funds.

“In order to ensure that the investment made by taxpayers was worthwhile, it is critical that we ensure the vaccine to prevent against the Zika virus is accessible to anyone who requires it,” the lawmakers wrote on Wednesday in a letter to Robert Speer, the Acting Secretary of the Army.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our
Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine — delivered straight to your inbox every weekday afternoon.